LungFit PH receives European CE mark approval to treat newborns
LungFit PH, Beyond Airās device for administering nitric oxide therapy, has received European CE mark approval for persistent pulmonary hypertension in newborns (PPHN). This approval allows the company to market the device in the European Union and all other countries that recognize this certification, and also extends its…